Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001214130-25-000009

Director sold 26 shares at $66.95 ($1,741)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

POTTER MYRTLE S · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-17 Sale : show line 1 in the form 10b5-1 −26 $66.95 $1,741 18,324 D
Open-market sales · 26 sh · avg $66.95 · $1,741
Loading xslF345X05/wk-form4_1761004125.xml…